Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Oncologica (Stockholm, Sweden)|April 10, 2024
Reducing renal function assessment prior to platinum-based chemotherapy: a real-world evaluationSuzanne Van der Gaag, Mariette Labots, Eleonora L Swart, et al.
BMJ Open|June 18, 2026
The DARO-flare trial: evaluating the impact of darolutamide on prostate-specific membrane antigen (PSMA) flare and its implications for imaging and staging of hormone-sensitive prostate cancer - study protocolSuzanne van der Gaag, André Vis, Imke Bartelink, et al.
Cancer Chemotherapy and Pharmacology|July 13, 2026
The value of target-site physiologically-based pharmacokinetics for high-affinity small molecules: a mechanistic foundation for precision dosing in oncology and hematologySuzanne van der Gaag, Daniela E Oprea-Lager, André N Vis, et al.
Biomedicines|December 23, 2022
Pharmacological Optimization of PSMA-Based Radioligand TherapySuzanne van der Gaag, Imke H Bartelink, André N Vis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 6, 2025
Exploring the Flare Phenomenon in Patients with Castration-Resistant Prostate Cancer: Enzalutamide-Induced PSMA Upregulation Observed on PSMA PETSuzanne van der Gaag, André N Vis, Imke H Bartelink, et al.
Clinical and Translational Science|May 15, 2026
Leveraging [18F]F-Piflufolastat PET for PBPK Prediction of Tissue Distribution and Therapy Optimization in Prostate CancerSuzanne van der Gaag, Mike J C Veerman, Habibe Yilmaz, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 26, 2025
Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET-Guided VerificationSuzanne van der Gaag, Tamara Jordens, Maqsood Yaqub, et al.
European Urology Oncology|December 18, 2024
Early Oncological Outcomes in Patients who Underwent Staging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Compared with Conventional Imaging Before Radical Prostatectomy and Extended Pelvic Lymph Node DissectionRosemarijn H Ettema, Jan-Jaap J Mellema, Dennie Meijer, et al.
The Lancet. Oncology|April 2, 2026
[177Lu]-PSMA-617-PSMA-617 in oligometastatic hormone sensitive prostate cancer (BULLSEYE): an open-label, randomised, phase 2 studyBastiaan M Privé, Walter Noordzij, Constantijn H J Muselaers, et al.
Pageof 1